NCT00205946View on ClinicalTrials.gov

The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

July 31, 2007

Conditions
Major Depressive Disorder
Interventions
DRUG

Bupropion

150 mg of bupropion administered 5 hours before fMRI scanning

DRUG

Placebo

Administered 5 hours prior to fMRI scanning (randomly assigned, double blind)

Trial Locations (2)

02114

The Depression Clinical and Research Program, Massachusetts General Hospital, Boston

02138

Affective Neuroscience Laboratory, Department of Psychology, Harvard University, Cambridge

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

lead

Affective Neuroscience Laboratory

OTHER

NCT00205946 - The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity | Biotech Hunter | Biotech Hunter